Positive alterations of viscoelastic and geometric properties in ovariectomized rat femurs with concurrent administration of ibandronate and PTH

Bone

Volumn 52, Issue 1, 2013, Pages 308-317

  Yang, Xiao ^a   Muthukumaran, Padmalosini ^a   DasDe, Shamal ^b   Teoh, Swee Hin ^c   Choi, Hoon ^d   Lim, Sung Kil ^e   Lee, Taeyong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c Nanyang Technological University   (Singapore)

^d Inje University   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

Author keywords

Additive effect; Bone geometry; Bone viscosity

Indexed keywords

COLLAGEN FIBER; HYDROXYAPATITE; IBANDRONIC ACID; PARATHYROID HORMONE[1-34];

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE GEOMETRY; BONE MATRIX; BONE STRENGTH; BONE STRUCTURE; CONTROLLED STUDY; CORTICAL BONE; CRYSTAL STRUCTURE; DETERIORATION; DRUG ACTIVITY; FEMALE; FEMUR; GEOMETRY; HISTOPATHOLOGY; LOW DRUG DOSE; METAPHYSIS; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PERIOSTEUM; POSTOPERATIVE COMPLICATION; RAT; TRABECULAR BONE; VISCOELASTICITY;

ANIMALS; DIPHOSPHONATES; ELASTICITY; FEMALE; FEMUR; MICROSCOPY, ELECTRON, SCANNING; OVARIECTOMY; PARATHYROID HORMONE; RATS; RATS, SPRAGUE-DAWLEY; TOMOGRAPHY, X-RAY COMPUTED; VISCOSITY;

EID: 84868462163     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.09.039     Document Type: Article

References (48)

1. Kanis J.A., Melton L.J., Christiansen C., et al. The diagnosis of osteoporosis. J Bone Miner Res 1994, 9:1137-1141.
2. Black D.M., Bouxsein M.L., Palermo L., et al. Randomized trial of once-weekly parathyroid hormone (1-84) on bone mineral density and remodeling. J Clin Endocrinol Metab 2008, 93:2166-2172.
3. Bauss F., Dempster D.W. Effects of ibandronate on bone quality: preclinical studies. Bone 2007, 40:265-273.
4. Black D.M., Greenspan S.L., Ensrud K.E., et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 2003, 349:1207-1215.
5. Yang X., Chan Y.H., Muthukumaran P., et al. Ibandronate does not reduce the anabolic effects of PTH in ovariectomized rat tibiae: a microarchitectural and mechanical study. Bone 2011, 48:1154-1163.
6. Ammann P., Badoud I., Barraud S., et al. Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength. J Bone Miner Res 2007, 22:1419-1425.
7. Ammann P., Laib A., Bonjour J.P., et al. Dietary essential amino acid supplements increase bone strength by influencing bone mass and bone microarchitecture in ovariectomized adult rats fed an isocaloric low-protein diet. J Bone Miner Res 2002, 17:1264-1272.
8. Turner C.H. Biomechanics of bone: determinants of skeletal fragility and bone quality. Osteoporos Int 2002, 13:97-104.
9. Miller L.M., Little W., Schirmer A., et al. Accretion of bone quantity and quality in the developing mouse skeleton. J Bone Miner Res 2007, 22:1037-1045.
10. Akkus O., Polyakova-Akkus A., Adar F., et al. Aging of microstructural compartments in human compact bone. J Bone Miner Res 2003, 18:1012-1019.
11. Akkus O., Adar F., Schaffler M.B. Age-related changes in physicochemical properties of mineral crystals are related to impaired mechanical function of cortical bone. Bone 2004, 34:443-453.
12. Richie R., Buehler M., Hansma P. Plasticity and toughness in bone 2009, 41-46. American Institute of Physics.
13. Chang Y.T., Chen C.M., Tu M.Y., et al. Effects of osteoporosis and nutrition supplements on structures and nanomechanical properties of bone tissue. J Mech Behav Biomed Mater 2011, 4:1412-1420.
14. Garner E., Lakes R., Lee T., et al. Viscoelastic dissipation in compact bone: implications for stress-induced fluid flow in bone. J Biomech Eng 2000, 122:166-172.
15. Brennan T.C., Rizzoli R., Ammann P. Selective modification of bone quality by PTH, pamidronate, or raloxifene. J Bone Miner Res 2009, 24:800-808.
16. Lee T., Lakes R.S., Lal A. Investigation of bovine bone by resonant ultrasound spectroscopy and transmission ultrasound. Biomech Model Mechanobiol 2002, 1:165-175.
17. Kim D.G., Huja S.S., Lee H.R., et al. Relationships of viscosity with contact hardness and modulus of bone matrix measured by nanoindentation. J Biomech Eng 2010, 132:024502.
18. Yamashita J., Furman B.R., Rawls H.R., et al. The use of dynamic mechanical analysis to assess the viscoelastic properties of human cortical bone. J Biomed Mater Res 2001, 58:47-53.
19. Lee T., Lakes R.S., Lal A. Resonant ultrasound spectroscopy for measurement of mechanical damping: comparison with broadband viscoelastic spectroscopy. Rev Sci Instrum 2000, 71:2855-2861.
20. Les C.M., Vance J.L., Christopherson G.T., et al. Long-term ovariectomy decreases ovine compact bone viscoelasticity. J Orthop Res 2005, 23:869-876.
21. Oliver W., Pharr G. An improved technique for determining hardness and elastic modulus using load and displacement sensing indentation. Microsc Microanal 1992, 7:1564.
22. Gittens S., Wohl G., Zernicke R., et al. Systemic bone formation with weekly PTH administration in ovariectomized rats. J Pharm Pharm Sci 2004, 7:27.
23. Bauss F., Wagner M., Hothorn L.H. Total administered dose of ibandronate determines its effects on bone mass and architecture in ovariectomized aged rats. J Rheumatol 2002, 29:990-998.
24. Stürmer E.K., Seidlová-Wuttke D., Sehmisch S., et al. Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone, and raloxifene. J Bone Miner Res 2006, 21:89-96.
25. Campbell G.M., Buie H.R., Boyd S.K. Signs of irreversible architectural changes occur early in the development of experimental osteoporosis as assessed by in vivo micro-CT. Osteoporos Int 2008, 19:1409-1419.
26. Buie H.R., Campbell G.M., Klinck R.J., et al. Automatic segmentation of cortical and trabecular compartments based on a dual threshold technique for in vivo micro-CT bone analysis. Bone 2007, 41:505-515.
27. Laib A., Barou O., Vico L., et al. 3D micro-computed tomography of trabecular and cortical bone architecture with application to a rat model of immobilisation osteoporosis. Med Biol Eng Comput 2000, 38:326-332.
28. Teo J.C.M., Si-Hoe K.M., Keh J.E.L., et al. Relationship between CT intensity, micro-architecture and mechanical properties of porcine vertebral cancellous bone. Clin Biomech 2006, 21:235-244.
29. Hasegawa Y., Schneider P., Reiners C. Age, sex, and grip strength determine architectural bone parameters assessed by peripheral quantitative computed tomography (pQCT) at the human radius. J Biomech 2001, 34:497-503.
30. Li X., Bhushan B. A review of nanoindentation continuous stiffness measurement technique and its applications. Mater Charact 2002, 48:11-36.
31. Barbier A., Martel C., de Vernejoul M.C., et al. The visualization and evaluation of bone architecture in the rat using three-dimensional X-ray microcomputed tomography. J Bone Miner Metab 1999, 17:37-44.
32. Sato M., Ma Y.L., Hock J.M., et al. Skeletal efficacy with parathyroid hormone in rats was not entirely beneficial with long-term treatment. J Pharmacol Exp Ther 2002, 302:304-313.
33. Vahle J.L., Sato M., Long G.G., et al. Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety. Toxicol Pathol 2002, 30:312-321.
34. Frolik C.A., Black E.C., Cain R.L., et al. Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure. Bone 2003, 33:372-379.
35. Poole K.E.S., Reeve J. Parathyroid hormone - a bone anabolic and catabolic agent. Curr Opin Pharmacol 2005, 5:612-617.
36. Bagi C.M., Ammann P., Rizzoli R., et al. Effect of estrogen deficiency on cancellous and cortical bone structure and strength of the femoral neck in rats. Calcif Tissue Int 1997, 61:336-344.
37. Lee T., Choi J.B., Schafer B.W., et al. Assessing the susceptibility to local buckling at the femoral neck cortex to age-related bone loss. Ann Biomed Eng 2009, 37:1910-1920.
38. Okimoto N., Tsurukami H., Okazaki Y., et al. Effects of a weekly injection of human parathyroid hormone (1-34) and withdrawal on bone mass, strength, and turnover in mature ovariectomized rats. Bone 1998, 22:523-531.
39. Ohnishi H., Nakamura T., Narusawa K., et al. Bisphosphonate tiludronate increases bone strength by improving mass and structure in established osteopenia after ovariectomy in rats. Bone 1997, 21:335-343.
40. Iwamoto J., Takeda T., Sato Y., et al. Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats. Exp Anim 2006, 55:457-466.
41. Kokoroghiannis C., Charopoulos I., Lyritis G., et al. Correlation of pQCT bone strength index with mechanical testing in distraction osteogenesis. Bone 2009, 45:512-516.
42. Ward K., Roberts S., Adams J., et al. Bone geometry and density in the skeleton of pre-pubertal gymnasts and school children. Bone 2005, 36:1012-1018.
43. Lee T., Pereira B.P., Chung Y.S., et al. Novel approach of predicting fracture load in the human proximal femur using non-invasive QCT imaging technique. Ann Biomed Eng 2009, 37:966-975.
44. Lee T. Predicting failure load of the femur with simulated osteolytic defects using noninvasive imaging technique in a simplified load case. Ann Biomed Eng 2007, 35:642-650.
45. Garnero P., Bauer D.C., Mareau E., et al. Effects of PTH and alendronate on type I collagen isomerization in postmenopausal women with osteoporosis: the PaTH study. J Bone Miner Res 2008, 23:1442-1448.
46. Boivin G., Meunier P.J. Effects of bisphosphonates on matrix mineralization. J Musculoskelet Neuronal Interact 2002, 2:538-543.
47. Turner R.T., Maran A., Lotinun S., et al. Animal models for osteoporosis. Rev Endocr Metab Disord 2001, 2:117-127.
48. Sehmisch S., Galal R., Kolios L., et al. Effects of low-magnitude, high-frequency mechanical stimulation in the rat osteopenia model. Osteoporos Int 2009, 20:1999-2008.